REFERENCES
- Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery. 1997;122:1083–1090.
- Aabed G, Furayh OA, Al-Lehbi A, Al Mana H, Al Ghamedi A, Helmy A. Calciphylaxis-associated second renal graft failure and patient loss: A case report and review of literature. Exp Clin Transplant. 2008;4:287–293.
- Nigwekar SU. Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol. 2008;3:1139–1143.
- Weenig RH, Sewell LD, Davis MD, . Calciphylaxis: Natural history, risk factor analysis and outcome. J Am Acad Dermatol. 2007;56:569–579.
- Rogers NM, Chang SH, Teubner DJO, Coates PTH. Hyperbaric oxygen as effective adjuvant therapy in the treatment of distal calcific uremic arteriolopathy. Nephrol Dial Transplant Plus. 2008;4:244–249.
- Colette BR, Wazny LD. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health-Syst Pharm. 2008;65:1419–1429.
- Hackett BC, McAleer MA. Calciphylaxis in a patient with normal renal function, response to treatment with sodium thiosulfate. Clin Exp Dermatol. 2009;34:39–42.
- Baker BL, Fitzgibbons CA, Buescher LS. Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol. 2007;123:269–270.
- Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: The emerging role of sodium thiosulfate. Cardiovasc Diabetol. 2005;4:4.
- Monney P, Nguyen QV, Perroud H, Descombes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Tranplant. 2004;19:2130–2132.
- Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004;43:1104–1108.
- Sodium thiosulfate. In: Klasco RK, ed. DRUGDEX. Greenwood Village, CO: Thomson Micromedex; 2007.
- Ackermann F, Levy A, Daugas E, . Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol. 2007;143:1336–1337.
- Hayden MR, Kolb LG, Khanna R. Calciphylaxis and the cardiometabolic syndrome. J Cardiometab Syndr. 2006;1:76–79.
- Farah M, Crawford RI, Levin A, Chan YC. Calciphylaxis in the current era: Emerging “Ironic” features? Nephrol Dial Transplant. 2011;26:191–195.
- Braverman B, Ivankovich AD, Shah G. Thiosulfate pharmacokinetics in normal and anuric dogs. Proc Soc Exp Biol Med. 1982;170:273–280.
- Brucculeri M, Cheigh J, Bauer G, Serur D. Long-term intravenous sodium thiosulphate in the treatment of a patient with calciphylaxis. Semin Dial. 2005;18:431–434.
- Araya CE, Fernnell RS, Neiberger RE, Dharnidharka VR. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1:1161–1166.
- Tokashiki K, Ishida A, Kouchi M, . Successful management of critical limb ischemia with intravenous sodium thiosulphate in a chronic hemodialysis patient. Clin Nephrol. 2006;66:140–143.
- Mataic D, Bastani B. Intraperitoneal sodium thiosulphate for the treatment of calciphylaxis. Ren Fail. 2006;28:361–363.